SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-115066
Filing Date
2022-04-22
Accepted
2022-04-22 16:01:01
Documents
14
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d330300ddef14a.htm DEF 14A 326002
2 GRAPHIC g330300dsp025.jpg GRAPHIC 136674
3 GRAPHIC g330300dsp026.jpg GRAPHIC 66438
4 GRAPHIC g330300g00a10.jpg GRAPHIC 51802
5 GRAPHIC g330300g00b10.jpg GRAPHIC 47822
6 GRAPHIC g330300g00c10.jpg GRAPHIC 45852
7 GRAPHIC g330300g00g03.jpg GRAPHIC 24582
8 GRAPHIC g330300g01a02.jpg GRAPHIC 30577
9 GRAPHIC g330300g01m02.jpg GRAPHIC 1722
10 GRAPHIC g330300g01q82.jpg GRAPHIC 34226
11 GRAPHIC g330300g02m02.jpg GRAPHIC 1699
12 GRAPHIC g330300g04q87.jpg GRAPHIC 14529
13 GRAPHIC g330300g05q87.jpg GRAPHIC 16528
14 GRAPHIC g330300g06q87.jpg GRAPHIC 20543
  Complete submission text file 0001193125-22-115066.txt   982536
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39692 | Film No.: 22845425
SIC: 2836 Biological Products, (No Diagnostic Substances)